Literature DB >> 29337176

Comparison of the diagnostic performances of ultrasonography, CT and fine needle aspiration cytology for the prediction of lymph node metastasis in patients with lymph node dissection of papillary thyroid carcinoma: A retrospective cohort study.

Na Lae Eun1, Eun Ju Son2, Jeong-Ah Kim3, Hye Mi Gweon4, Jung-Hyun Kang5, Ji Hyun Youk6.   

Abstract

PURPOSE: To evaluate the diagnostic performances of ultrasonographic (US) findings, computed tomography (CT) findings and fine needle aspiration cytology (FNAC) for the prediction of cervical lymph node (LN) metastases of papillary thyroid carcinoma (PTC) to determine which LN should be dissected.
METHODS: 376 LNs in 302 patients who underwent both US-guided skin surface LN markings and CT before LN dissection were analyzed retrospectively. Indications for LN dissection were suspicious US findings of LN metastases (n = 300), suspicious CT findings (n = 67) or surgeon's request (n = 9). Diagnostic performances of US, CT and FNAC (including thyroglobulin (Tg)) were evaluated. The correlations of suspicious US, CT finding or malignant FNAC with the size, number and the presence of extranodal extension of metastatic LNs were analyzed.
RESULTS: US indication of LN dissection was significantly correlated with malignancy (p < .0001). Values of area under the curve of highly suspicious US findings and FNAC+Tg were significantly higher than that of CT (0.786, 0.878, 0.585, p < .0001, respectively). Suspicious US, CT findings and malignant FNAC+Tg were significantly associated with the largest size of metastatic LNs (p = .003, p = .0003, and p = .0006, respectively) and total number of metastatic LNs (p = .007, p = .038, and p = .005, respectively).
CONCLUSION: The diagnostic performance of US or FNAC was superior to CT and highly suspicious US findings could be complimentary to FNAC results in predicting LN metastases of PTC. LN dissection should be performed for the LNs with any suspicious US findings or malignant FNAC results rather than LNs with only suspicious CT findings.
Copyright © 2018 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29337176     DOI: 10.1016/j.ijsu.2017.12.036

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  10 in total

1.  Diagnostic performance of CT in detection of metastatic cervical lymph nodes in patients with thyroid cancer: a systematic review and meta-analysis.

Authors:  Se Jin Cho; Chong Hyun Suh; Jung Hwan Baek; Sae Rom Chung; Young Jun Choi; Jeong Hyun Lee
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

2.  Diagnostic accuracy of ultrasound, CT and their combination in detecting cervical lymph node metastasis in patients with papillary thyroid cancer: a systematic review and meta-analysis.

Authors:  Jian Yang; Fengyan Zhang; Ying Qiao
Journal:  BMJ Open       Date:  2022-07-04       Impact factor: 3.006

3.  Diagnostic accuracy of single-source dual-energy computed tomography and ultrasonography for detection of lateral cervical lymph node metastases of papillary thyroid carcinoma.

Authors:  Lin Li; Sai-Nan Cheng; Yan-Feng Zhao; Xiao-Yi Wang; De-Hong Luo; Yong Wang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

4.  Diagnostic values of F-18 FDG PET or PET/CT, CT, and US for Preoperative Lymph Node Staging in Thyroid Cancer: A Network Meta-Analysis.

Authors:  Keunyoung Kim; Sung-Ryul Shim; Sang-Woo Lee; Seong-Jang Kim
Journal:  Br J Radiol       Date:  2021-02-17       Impact factor: 3.039

5.  Using Diffusion-Weighted MRI to Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Feasibility Study.

Authors:  Heng Zhang; Shudong Hu; Xian Wang; Wenhua Liu; Junlin He; Zongqiong Sun; Yuxi Ge; Weiqiang Dou
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-12       Impact factor: 5.555

6.  Diagnostic value of cytology, thyroglobulin, and combination of them in fine-needle aspiration of metastatic lymph nodes in patients with differentiated thyroid cancer: A systematic review and network meta-analysis.

Authors:  Yixin Xu; Dapeng Wu; Wenting Wu; Jian Jiang; Cheng Xi; Nianyuan Ye; Yibo Wang; Xuezhong Xu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Preoperative Nodal US Features for Predicting Recurrence in N1b Papillary Thyroid Carcinoma.

Authors:  Na Lae Eun; Jeong-Ah Kim; Hye Mi Gweon; Ji Hyun Youk; Eun Ju Son
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639

8.  Prediction Model of Pathologic Central Lymph Node Negativity in cN0 Papillary Thyroid Carcinoma.

Authors:  Xiujie Shu; Lingfeng Tang; Daixing Hu; Yuanyuan Wang; Ping Yu; Zhixin Yang; Chang Deng; Denghui Wang; Xinliang Su
Journal:  Front Oncol       Date:  2021-09-27       Impact factor: 6.244

9.  Analysis of risk factors for lateral lymph node metastasis in papillary thyroid carcinoma: A retrospective cohort study.

Authors:  Qiang Liu; Wen-Ting Pang; Yan-Bo Dong; Zhen-Xiao Wang; Ming-Hang Yu; Xue-Feng Huang; Liang-Fa Liu
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-04-18

10.  Thyroglobulin Measurement Through Fine-Needle Aspiration for Optimizing Neck Node Dissection in Papillary Thyroid Cancer.

Authors:  Xi Jia; Yuanbo Wang; Yan Liu; Xiang Wang; Xiaobao Yao; Runyi Tao; Hui Liu; Aimin Yang; Rui Gao
Journal:  Ann Surg Oncol       Date:  2021-08-12       Impact factor: 5.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.